An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
The purpose of this study is to predict response to Erbitux as a single agent in patients with metastatic colon cancer
Metastatic Colorectal Cancer
DRUG: Cetuximab
Prediction of response to Erbitux in subjects with metastatic colorectal cancer
Radiographic Response
The purpose of this study is to predict response to Erbitux as a single agent in patients with metastatic colon cancer